PI4KIIIBETA INHIBITORS

The invention relates to compounds of formula (I) which are inhibitors of kinase activity, pharmaceutical formulations containing the compounds and their uses in treating and preventing viral infections and disorders caused or exacerbated by the viral infection wherein R1, R2, R3, R4a, R4b, R4c, R5,...

Full description

Saved in:
Bibliographic Details
Main Authors BERTRAND, Sophie Marie, DOWN, Kenneth, BARTON, Nicholas Paul, GRAY, Matthew
Format Patent
LanguageEnglish
Published 06.09.2021
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The invention relates to compounds of formula (I) which are inhibitors of kinase activity, pharmaceutical formulations containing the compounds and their uses in treating and preventing viral infections and disorders caused or exacerbated by the viral infection wherein R1, R2, R3, R4a, R4b, R4c, R5, W, X, Y and Z are defined herein.
AbstractList The invention relates to compounds of formula (I) which are inhibitors of kinase activity, pharmaceutical formulations containing the compounds and their uses in treating and preventing viral infections and disorders caused or exacerbated by the viral infection wherein R1, R2, R3, R4a, R4b, R4c, R5, W, X, Y and Z are defined herein.
Author GRAY, Matthew
BARTON, Nicholas Paul
BERTRAND, Sophie Marie
DOWN, Kenneth
Author_xml – fullname: BERTRAND, Sophie Marie
– fullname: DOWN, Kenneth
– fullname: BARTON, Nicholas Paul
– fullname: GRAY, Matthew
BookMark eNrjYmDJy89L5WQQC_A08fb09HRyDXFU8PTz8HTyDPEPCuZhYE1LzClO5YXS3Awqbq4hzh66qQX58anFBYnJqXmpJfEBHoZGBkYGpqaGBsYmjobGRCoDAD4IIgk
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID PH12020551034A1
GroupedDBID EVB
ID FETCH-epo_espacenet_PH12020551034A13
IEDL.DBID EVB
IngestDate Fri Jul 19 13:09:10 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_PH12020551034A13
Notes Application Number: PH20201551034
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210906&DB=EPODOC&CC=PH&NR=12020551034A1
ParticipantIDs epo_espacenet_PH12020551034A1
PublicationCentury 2000
PublicationDate 20210906
PublicationDateYYYYMMDD 2021-09-06
PublicationDate_xml – month: 09
  year: 2021
  text: 20210906
  day: 06
PublicationDecade 2020
PublicationYear 2021
RelatedCompanies GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
RelatedCompanies_xml – name: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Score 3.3469443
Snippet The invention relates to compounds of formula (I) which are inhibitors of kinase activity, pharmaceutical formulations containing the compounds and their uses...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title PI4KIIIBETA INHIBITORS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210906&DB=EPODOC&locale=&CC=PH&NR=12020551034A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMUg0NUsyMErTTUpJTNU1STYz1k00sUjUNTY1TwFd9G6YBB5w8_Uz8wg18YowjWBiyIXthQGfE1oOPhwRmKOSgfm9BFxeFyAGsVzAayuL9ZMygUL59m4hti5q0N6xEWiZoZmai5Ota4C_i7-zmrOzbYCHml-QrSFQ0sAUdHyciSOws8QKakmDjtp3DXMCbUwpQK5V3AQZ2AKABuaVCDEwpeYJM3A6wy5fE2bg8IXOeQOZ0OxXLMIgFuBp4u3p6enkGuKo4Onn4enkGeIfFCzKoOLmGuLsoQu0IB7uofgADxTnGIsxsAD7-qkSDAoWlolJhimWFsYGqZYmhpZplqmWiSbmyaZGaakpycAcIskgi9coKQLy0gxcoFACL5Iyk2FgKSkqTZUF1qolSXLgsAAAhol2Ww
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3JTsMwEB1VBVFuUKjYCj1UuUVkcbZDhJpNMW0WlYB6i7I4EgdKRYP4fWwrZbnAzfJIY3uk5_GMZwGYSoWml5LSiGVdEBFVuioWyCxEVTNq1uhdLrnDLYr18BHdr7RVD152uTC8TugHL45IEVVRvLf8vt58O7E8Hlu5vS2f6dTrXZDZntBZxwoLM9QFz7H9NPESV3BdOw2FeGnLlChprHwcmlFjac9gBXrZ6-nJYYkpm59aJTiC_ZQyXLfH0CPrIQzcXfO1IRxE3Z83HXbw257AKMVojjF2_Gw2wXGIHZwly4dTmAZ-5oYiXSD_OlCehr-2o46gT219cgYT0ypKubZMVSIWkq3GIlaBjEpTGlJXFCHnMP6T1cU_9BsYhFm0yBc4nl_CIZMYD5jSr6Dfvr2TMdWwbXnN5fIJNzB5SA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=PI4KIIIBETA+INHIBITORS&rft.inventor=BERTRAND%2C+Sophie+Marie&rft.inventor=DOWN%2C+Kenneth&rft.inventor=BARTON%2C+Nicholas+Paul&rft.inventor=GRAY%2C+Matthew&rft.date=2021-09-06&rft.externalDBID=A1&rft.externalDocID=PH12020551034A1